Date | Speaker(s) | Presentation Title Sort descending |
---|---|---|
June 2016 | Douglas L. Weed, M.D., Ph.D., M.P.H. |
After the NCI: Methods, Mountains, and Mischief |
April 2019 | Noelle J. LoConte, M.D. |
Alcohol and Cancer: A Call to Action for the Oncology Community |
May 2022 | Kevin Shield, Ph.D. |
Alcohol, Cancer and the Potential Impact of the COVID-19 Pandemic on Future Alcohol-attributable Cancer Rates |
February 2016 | John F. McDonald, Ph.D. |
An Integrated Approach to Ovarian Cancer Diagnostics and Personalized Therapy |
February 2019 | Joel Palefsky, M.D. |
Anal HPV Infection and Disease: A Model for Understanding All Things HPV |
May 2015 | Ian Barron, Ph.D. |
Aspirin & Breast Cancer — Adjuvant Treatment & Mechanisms of Action |
January 2019 | Andrew Chan, M.D., M.P.H. |
Aspirin for the Precision Prevention of Colorectal Cancer |
September 2022 | A. Janet Tomiyama, Ph.D. |
Avoiding Unintended Consequences of a Weight-Centered Approach to Cancer Prevention |
June 2021 | Lisa Carter-Harris, Ph.D. |
Beyond a Closed-Ended Question: Understanding the Decision to Screen or Not for Lung Cancer |
November 2014 | Erin Costanzo, Ph.D. |
BioBehavioral Influences on Recovery Following Hematopoietic Stem Cell Transplantation |